Sallin Aymeric 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Sallin Aymeric
Director
Transactions
- Award
Common Stock
[F1]2024-01-02+178,000→ 178,000 total - Award
Stock Option (Right to Buy)
[F2]2024-01-02+228,000→ 228,000 totalExercise: $0.66Exp: 2034-01-01→ Common Stock (228,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027.
- [F2]This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027.
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Aymeric Sallin|2024-01-04